Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5Parasomnias 3Neoplasms 3Tuberous Sclerosis 2Smith-Magenis Syndrome 2Lung Neoplasms 2Autism Spectrum Disorder 2Angelman Syndrome 2Weight Loss 1Squamous Cell Carcinoma of Head and Neck 1Sleep Wake Disorders 1Sleep Disorders, Circadian Rhythm 1Relapsed Malignant Solid Tumor 1Radiodermatitis 1Radiation Injuries 1Polycystic Ovary Syndrome 1Pain 1Neoplasm Metastasis 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fatigue 1Depression 1Delirium 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Brain Neoplasms 1Barrett Esophagus 1Anorexia 1

Interventions

Yoga 2Therapeutics 2Educational Status 2Early Intervention, Educational 2Behavior Therapy 2exemestane 1Zolpidem 1Venlafaxine Hydrochloride 1Valeriana extract 1Uncertainty 1Triptorelin Pamoate 1Tamoxifen 1Surveys and Questionnaires 1Psychosocial Intervention 1Psychiatric Rehabilitation 1N-((1-((5-(4-fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide 1Methods 1Melatonin 1Hypnosis 1Gonadotropin-Releasing Hormone 1Exercise Test 1Donepezil 1Counseling 1Cognitive Behavioral Therapy 1Acupuncture Therapy 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Sleep Wake Disorders × Melatonin × Clear all
NCT01906866 2024-04-23

Efficacy and Safety of CircadinĀ® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

Neurim Pharmaceuticals Ltd.

Phase 3 Completed
125 enrolled 22 charts

Autism Spectrum Disorder, Sleep Wake Disorders, Tuberous Sclerosis, Angelman Syndrome, Parasomnias, Smith-Magenis Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚔